- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Expert Interviews
CPP Patient Case: When to Stop Treatment
April 25, 2022
Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss a central precocious puberty (CPP) patient case regarding factors that would lead a physician to either stop treating a patient or continue with treatment.
CPP Patient Case: When to Treat
April 25, 2022
Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss a central precocious puberty (CPP) patient case regarding factors that would lead a physician to treat a patient.
Individualizing Treatment Decisions in Girls With Central Precocious Puberty
April 25, 2022
Karen O. Klein, MD, and Kent L. Reifschneider, MD, discuss individualizing treatment decisions in girls with central precocious puberty (CPP).
Unmet Needs in Diabetes Management
April 21, 2022
Dr Diana Isaacs provides insight on current challenges in the clinical treatment of patients with diabetes and shares clinical pearls for the use of CGMs in disease management.
Future CGM Advancements for Diabetes Management
April 21, 2022
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, evaluates upcoming CGM advances in the pipeline for the management of diabetes.
Emerging CGM Systems in Diabetes Management
April 14, 2022
Dr Diana Isaacs reviews the significance of Eversense’s recent approval for a 180-day indication and the potential role of Dexcom G7 in the diabetes treatment landscape.
Evolution of CGMs in Managing Diabetes
April 14, 2022
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, comments on the accuracy and selection of CGMs in treating diabetes and shares insight on the evolution of CGM systems over the past year.
Utilizing CGMs for Diabetes Management in COVID-19
April 07, 2022
An expert in diabetes management discusses the role of CGMs in treating diabetes during the COVID-19 pandemic and the benefits of using CGM in telemedicine.
Patient Selection for CGMs in Diabetes
April 07, 2022
Dr Diana Isaacs provides insight on patient factors to consider for CGM use in diabetes treatment.
Role of Continuous Glucose Monitoring (CGM) in Diabetes Management
April 07, 2022
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, reviews the advantages of CGMs in treating type 1 and type 2 diabetes and how CGMs can improve glycemic control and quality of life in patients.